Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Badrinath

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Indian Journal of Cancer|January 13, 2004
Haematologic and immunophenotypic profile of acute myeloid leukemia: an experience of Tata Memorial HospitalS Ghosh, S C Shinde, G S Kumaran, et al.
Cytometry. Part B, Clinical Cytometry|September 23, 2008
Immunophenotypic profile of acute leukemia: critical analysis and insights gained at a tertiary care center in IndiaS Gujral, Y Badrinath, A Kumar, et al.
Oncotarget|December 20, 2018
Clinical impact of measurable residual disease monitoring by ultradeep next generation sequencing in <i>NPM1</i> mutated acute myeloid leukemiaNikhil Patkar, Rohan Kodgule, Chinmayee Kakirde, et al.
Oncotarget|February 8, 2019
Correction: Clinical impact of measurable residual disease monitoring by ultradeep next generation sequencing in <i>NPM1</i> mutated acute myeloid leukemiaNikhil Patkar, Rohan Kodgule, Chinmayee Kakirde, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Indian Journal of Cancer|January 13, 2004
Haematologic and immunophenotypic profile of acute myeloid leukemia: an experience of Tata Memorial HospitalS Ghosh, S C Shinde, G S Kumaran, et al.
Cytometry. Part B, Clinical Cytometry|September 23, 2008
Immunophenotypic profile of acute leukemia: critical analysis and insights gained at a tertiary care center in IndiaS Gujral, Y Badrinath, A Kumar, et al.
Oncotarget|December 20, 2018
Clinical impact of measurable residual disease monitoring by ultradeep next generation sequencing in <i>NPM1</i> mutated acute myeloid leukemiaNikhil Patkar, Rohan Kodgule, Chinmayee Kakirde, et al.
Oncotarget|February 8, 2019
Correction: Clinical impact of measurable residual disease monitoring by ultradeep next generation sequencing in <i>NPM1</i> mutated acute myeloid leukemiaNikhil Patkar, Rohan Kodgule, Chinmayee Kakirde, et al.
Pageof 3